Bilateral Ultrasound-Guided Intra Muscular Quadratus Lumborum Block Versus Trans Muscular Quadratus Lumborum Block for Peri-Operative Analgesia in Abdominal Surgeries in Pediatric Patients. A Comparative Controlled Randomized Study.
1 other identifier
interventional
66
1 country
1
Brief Summary
To compare between the intra muscular quadratous lamborum and the Trans muscular quadratous lamborum in pediatric population under going abdominal surgeries regards to first request of rescue analgesia, degree of pain relief, effect on hemo dynamic stability and incidence of complications.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 25, 2018
CompletedFirst Submitted
Initial submission to the registry
December 2, 2018
CompletedFirst Posted
Study publicly available on registry
July 23, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2019
CompletedJanuary 22, 2020
January 1, 2020
11 months
December 2, 2018
January 19, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Time of the first postoperative analgesic request
(duration of the block, time spent post-operative before rescue opioid is needed at pain score of 6 or higher, up to 12 hours post operative.
starting 15 minutes post extubation, then at time intervals of 30 minutes , 60 minutes, 6 hours and 12 hours
Secondary Outcomes (6)
total opioid consumption over the first 12 hours.
through out the first 12 hours post operative.
Pain score up to 12 hours after surgery.
through out the first 12 hours post operative.
Block failure
through out the first hour post operative.
Ease of performance of each technique
through out the block performance time
Block performance time
starting from probe contact with skin till 30 minutes.
- +1 more secondary outcomes
Other Outcomes (6)
patient's heart rate
starting from 5 minutes after intubation till 30 minutes after extubation
patient's systolic blood pressure
starting from 5 minutes after intubation till 30 minutes after extubation
patient's diastolic blood pressure
starting from 5 minutes after intubation till 30 minutes after extubation
- +3 more other outcomes
Study Arms (3)
Trans Muscular Quadratus Lumborum fascial plane Block
ACTIVE COMPARATORIn group (Trans Muscular Quadratus Lumborum Block),will undergo ultrasound guided trans-muscular quadratus lamborum block as follows: A 22 G echogenic needle will be inserted in plane from the posterior (medial) end of the probe and directed for the fascial plane between the Quadratus Lumborum and the Psoas Major muscles through the Quadratus Lumborum muscle. Once the needle is confirmed in correct location, 1 mL of saline will be injected after negative aspiration. Then 0.5 mL/Kg per side of bupivacaine 0.25% will be injected. The spread of the injectate should be observed to distribute within this plane. This technique will be repeated to the other side.
Intra Muscular Quadratus Lumborum fascial plane Block
ACTIVE COMPARATORIn group Intra Muscular Quadratus Lumborum Block ,will undergo ultrasound guided intra-muscular quadratus lamborum (QL) block as follows: A 22 G echogenic needle will be inserted in plane from ventral (lateral) edge of the probe and advanced until penetration of QL muscle fascia is observed. Once the needle is confirmed in correct location, 1 mL of saline will be injected after negative aspiration. Then 0.5 mL/Kg per side of bupivacaine 0.25% will be injected. The spread of the injectate should be observed to distribute within this plane. This technique will be repeated to the other side.
group c → control
PLACEBO COMPARATORgroup c → control ,will receive conventional analgesia in the form of paracetamol with 15 mg\\ k.g every 6 hours, and naluphin 0.1 mg \\kg on demands
Interventions
A 22 G echogenic needle will be inserted in plane from the posterior (medial) end of the probe and directed for the fascial plane between the Quadratus Lumborum and the Psoa Major muscles through the Quadratus Lumborum muscle. Once the needle is confirmed in correct location, 1 mL of saline will be injected after negative aspiration. Then 0.5 mL/Kg of bupivacaine 0.25% will be injected. The spread of the injectate should be observed to distribute within this plane. This technique will be repeated to the other side.
A 22 G echogenic needle will be inserted in plane from ventral (lateral) edge of the probe and advanced until penetration of QL muscle fascia is observed. Once the needle is confirmed in correct location, 1 mL of saline will be injected after negative aspiration. Then 0.5 mL/Kg of bupivacaine 0.25% will be injected. The spread of the injectate should be observed to distribute within this plane. This technique will be repeated to the other side.
Eligibility Criteria
You may qualify if:
- Children age starting from 5 to 12 years.
- Genders eligible for study: both sexes.
- American Society Of Anesthesia (ASA) I-III.
- Scheduled to undergo laparoscopy.
You may not qualify if:
- Refusal of regional block or patients requiring emergency procedures.
- Known Local Anesthetics drug sensitivity
- Bleeding disorders with International Normalised Ratio (INR) \> 1.5 and/or platelets \< 100 000.
- Skin lesions or wounds at site of proposed needle insertion.
- Evidence of peritonitis or septicemia.
- Hepatic disease or enlargement.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Abu ElReesh hospital, Cairo university Hospital,Kasr Alini
Cairo, 11562, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Patients, parents and data analysts will be blinded to group assignments.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 2, 2018
First Posted
July 23, 2019
Study Start
October 25, 2018
Primary Completion
October 1, 2019
Study Completion
October 1, 2019
Last Updated
January 22, 2020
Record last verified: 2020-01
Data Sharing
- IPD Sharing
- Will not share